JA

Jahanzeb Azam Kamal

Active Director Additional Director DIN 10896621
DIN 10896621 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jahanzeb Azam Kamal

Data last updated:

Jahanzeb Azam Kamal is an Additional Director at Vinishaw Pharmaceutical Private Limited (since 2025). The company operates in Pharma.

DIN 10896621
Primary Designation Additional Director
Industry Pharma
First Appointment 22 Jan 2025
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Jan 20252020Active

Board colleagues of Jahanzeb Azam Kamal

NameDINCompanyDesignation
Prashant Mishra10804517Vinishaw Pharmaceutical Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Vinishaw Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Jahanzeb Azam Kamal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jahanzeb Azam Kamal

Jahanzeb Azam Kamal currently holds 1 directorship: Vinishaw Pharmaceutical Private Limited (Additional Director, since 22 Jan 2025).

Jahanzeb Azam Kamal was first appointed on 22 Jan 2025 as Additional Director at Vinishaw Pharmaceutical Private Limited.

The current boards of Jahanzeb Azam Kamal's companies include Prashant Mishra (Vinishaw Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available